Aspire Biopharma Holdings, Inc. Announces CEO Transition
ESTERO, FL / / July 30, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced that the Company's Board of Directors (Board) has appointed Kraig Higginson as interim Chief Executive Officer (CEO), effective July 24, 2025. Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for four years. Michael C. Howe has resigned as CEO and as a member of the Board. The Board thanks Mr. Howe for his contributions to the Company and plans to initiate a search for a permanent CEO.
"On behalf of the entire Board, I want to thank Michael for his contributions to the Company and wish him the very best in the future," said Kraig Higginson, Interim Chief Executive Officer of Aspire. "I look forward to leading Aspire with the same level of commitment as if I were in the role permanently, with a goal of continuing to execute on maximizing the potential of Aspire's powerful and differentiated drug delivery platform. We are fortunate to have a capable leadership team, and we will continue to focus on positioning the business for long-term success."
The Company also announced the resignations of Mr. Gary E. Stein and Ms. Barbara Sher from the Board, effective immediately. The Aspire Board is very grateful for Mr. Steins's and Ms. Sher's outstanding service as members of the Board and for all of the thoughtful insights and valuable contributions they provided during their tenures.
In connection with this transition, the Board of Directors appointed Howard Doss, to serve as Director and Chairman of the Audit Committee of the Company, effective immediately.
Mr. Doss, age 71, has served as the Chief Financial Officer of PowerUp from August 2023 until February 2025. He is a seasoned chief financial officer and accountant. He served as Chief Financial Officer of Kernel Group Holdings, Inc. In 2021, he served as Chief Financial Officer of Aesther Healthcare Acquisition Corp., a special purpose acquisition company until it consummated its initial business combination in February 2023. He has also served as chief financial officer of Trade Health, Inc., an online marketplace for health traded on Nasdaq under the symbol "SCNX." Mr. Doss has served in a variety of capacities with accounting and investment firms. He joined the staff of Seidman & Seidman (BDO Seidman, Dallas) in 1977 and in 1980 he joined the investment firm Van Kampen Investments, opening the firm's southeast office in Tampa, Florida in 1982. He remained with the firm until 1996 when he joined Franklin Templeton. After working for the Principal Financial Group office in Tampa, Florida, Mr. Doss was City Executive for U.S. Trust in Sarasota, Florida, responsible for high-net-worth individuals. He retired from that position in 2009. He served as CFO and Director for Sansur Renewable Energy, an alternative energy development company, from 2010 to 2012. Mr. Doss has also served as President of Staradio Corp. since 2005. Mr. Doss is a member of the America Institute of CPA's. He is a graduate of Illinois Wesleyan University.
About Aspire Biopharma, Inc.
Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG AdvisoryKevin McGrath+1-646-418-7002kevin@pcgadvisory.com
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
13 minutes ago
- CBS News
Schools and counties begin to see payment delays as Pennsylvania's budget stalemate hits a month
Democratic Gov. Josh Shapiro's administration says billions of dollars in aid to Pennsylvania's schools and human services will be delayed, as he and the politically divided Legislature struggle to end what is now a monthlong budget stalemate. State-supported universities, libraries, early-childhood education programs and county health departments also will see delays in payments, Shapiro's administration said in letters sent Tuesday to providers. "I recognize this information is concerning, and it is equally concerning to both me and the governor," Budget Secretary Uri Monson said in the letters. "Our administration continues to work diligently to find agreement between the House and Senate and we will work to support you and your organization as you manage the current situation." Borrowing isn't widespread by counties and school districts to cover for late state payments, and some have reserves they can tap. But borrowing may grow if the stalemate drags well into August. Budget stalemates are also playing out in Michigan and North Carolina, where Democratic governors are sharing power with Republican legislators. Without the governor's signature on a new spending plan, the Pennsylvania state government lost some of its spending authority starting July 1. Pennsylvania school districts, which received more than $11 billion last year from the state for operations, will see delays on more than $2 billion in payments through August, Shapiro's administration said. District officials have said the poorest districts might have to borrow money if aid is delayed in August, and the Pennsylvania School Boards Association says the stalemate is causing districts to reconsider how they spend, such as leaving teaching positions unfilled or putting off purchases of student laptops. A school board's official, Andy Christ, said the state didn't reimburse districts for the cost of borrowing during past stalemates. Universities, such as Penn State and state-run system schools, will see delays on more than $200 million in aid, and counties will not get on-time payments of $390 million to child welfare agencies, the Shapiro administration said. The County Commissioners Association of Pennsylvania said its members are "growing more and more concerned about the consequences" of the stalemate, particularly on human services such as mental health counseling, child welfare, and drug and alcohol treatment. More than $100 million in payments to a range of other agencies, nonprofits and programs will also be delayed, according to the administration, and it said it cannot distribute money to early childhood education providers. For weeks, Shapiro and top Republican lawmakers have said they are engaged in closed-door discussions to try to find a compromise. The state House and Senate have not scheduled voting sessions for this week. The biggest issues for Republicans are curbing Shapiro's $51.5 billion spending proposal — driven by a massive increase in Medicaid costs — and their push to regulate and tax tens of thousands of slot-machine-like cash-paying "skill" games that are popping up everywhere. Top priorities for Shapiro and Democrats are boosting funding for public schools and public transit agencies. During a stalemate, the state is legally bound to make debt payments, cover Medicaid costs for millions of Pennsylvanians, issue unemployment compensation payments, keep prisons open and ensure state police are on patrol. All state employees under a governor's jurisdiction are typically expected to report to work and be paid as scheduled. Michigan's Democratic-controlled Senate and the Republican-controlled House of Representatives remain far apart on numerous proposals, including funding for schools and roads. The chambers' leaders have accused each other of refusing to negotiate. If lawmakers and Democratic Gov. Gretchen Whitmer don't pass a budget by the Oct. 1 start of the state's fiscal year, they risk a government shutdown. In North Carolina, where Republicans control the Legislature, a budget deal likely isn't expected until late August at the earliest. Teacher and state employee salary raises, tax cuts and eliminating vacant government positions have been among the leading differences in competing spending plans. State government is in no danger of a shutdown, and the Legislature sent Democratic Gov. Josh Stein a stopgap spending plan on Wednesday. ___ Associated Press reporters Gary D. Robertson in Raleigh, North Carolina, and Isabella Volmert in Lansing, Michigan, contributed. Follow Marc Levy on X at:
Wall Street Journal
13 minutes ago
- Wall Street Journal
The Economist Trump Targeted Over ‘Rigged' Jobs Data
About a year into her tenure as the head of the Bureau of Labor Statistics, Erika McEntarfer stood before the Atlanta Economics Club and laid out what she saw as two obstacles to her job producing the government's economic data: the cost of doing that work was rising, and the number of people responding to surveys was declining. The bureau, she said, would aim to modernize and keep going. 'If we succeed, the U.S. can continue to have this rich set of economic data,' she told the group.
Yahoo
34 minutes ago
- Yahoo
Align Technology (ALGN) Dives 37% on Lower Price Target, Pessimistic Rating
We recently published . Align Technology, Inc. (NASDAQ:ALGN) is one of the worst-performing stocks on Thursday. Align Technology fell to a new low on Thursday as investors sold off positions after missing earnings expectations and earning a lower price target and pessimistic rating from an investment firm. In intra-day trading, Align Technology, Inc. (NASDAQ:ALGN) dropped to its lowest price of $127.7 before slight buying pushed the company's share price higher to end the day just down by 36.63 percent at $129.01 apiece. This followed mixed earnings performance during the quarter that saw the company record a non-GAAP net income of $181.1 million, flat from last year. GAAP net income, on the other hand, amounted to $124.6 million, or 29 percent higher than the $93.2 million in the same period last year. Net revenues, on the other hand, dipped by 1.6 percent to $1.012 billion from $1.028 billion year-on-year. In other developments, Mizuho reduced its price target for Align Technology, Inc. (NASDAQ:ALGN) to $210 from $245 previously, but maintained an 'outperform' rating for the stock. Mizuho's revision followed reports about June trends, which fell short of expectations, despite the company's hosting of an 'upbeat analyst meeting' in May this year. Pixabay/Public domain Additionally, the revision reflected the weaker-than-expected patient conversion rates despite iTero scans and Invisalign doctor case submissions appearing to remain on track. While we acknowledge the potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
